200 related articles for article (PubMed ID: 30867899)
1. Genomic aberrations in cell cycle genes predict progression of
Heinrich MC; Patterson J; Beadling C; Wang Y; Debiec-Rychter M; Dewaele B; Corless CL; Duensing A; Raut CP; Rubin B; Ordog T; van de Rijn M; Call J; Mühlenberg T; Fletcher JA; Bauer S
Clin Sarcoma Res; 2019; 9():3. PubMed ID: 30867899
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
3. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
Belinsky MG; Skorobogatko YV; Rink L; Pei J; Cai KQ; Vanderveer LA; Riddell D; Merkel E; Tarn C; Eisenberg BL; von Mehren M; Testa JR; Godwin AK
Genes Chromosomes Cancer; 2009 Oct; 48(10):886-96. PubMed ID: 19585585
[TBL] [Abstract][Full Text] [Related]
4. Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.
Merten L; Agaimy A; Moskalev EA; Giedl J; Kayser C; Geddert H; Schaefer IM; Cameron S; Werner M; Ströbel P; Hartmann A; Haller F
Am J Clin Pathol; 2016 Dec; 146(6):718-726. PubMed ID: 28028119
[TBL] [Abstract][Full Text] [Related]
5. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
Li JX; Sun L; Zhao S; Shao B; Guo YH; Chen S; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):346-356. PubMed ID: 37072312
[No Abstract] [Full Text] [Related]
6. Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
Zalcberg JR
Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
Ihle MA; Huss S; Jeske W; Hartmann W; Merkelbach-Bruse S; Schildhaus HU; Büttner R; Sihto H; Sundby Hall K; Eriksson M; Reichardt P; Joensuu H; Wardelmann E
PLoS One; 2018; 13(2):e0193048. PubMed ID: 29451912
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in cell cycle regulation-associated genes may promote primary progression of gastrointestinal stromal tumors.
Li P; Li M; Wang K; Liu Y; Wang Y; Zhao D; Chai J; Ma J; Li X; Wei J; Fan L; Zhang F; Ye J; Yan Q; Guo S; Wang Z
Lab Invest; 2020 Mar; 100(3):426-437. PubMed ID: 31570771
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring
Ohshima K; Nagashima T; Fujiya K; Hatakeyama K; Watanabe Y; Morimoto K; Kamada F; Shimoda Y; Ohnami S; Naruoka A; Serizawa M; Ohnami S; Kenmotsu H; Shiomi A; Tsubosa Y; Bando E; Sugiura T; Sugino T; Terashima M; Uesaka K; Urakami K; Akiyama Y; Yamaguchi K
Cancer Res Commun; 2023 Apr; 3(4):684-696. PubMed ID: 37377752
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS).
Saponara M; Urbini M; Astolfi A; Indio V; Ercolani G; Del Gaudio M; Santini D; Pirini MG; Fiorentino M; Nannini M; Lolli C; Mandrioli A; Gatto L; Brandi G; Biasco G; Pinna AD; Pantaleo MA
Oncotarget; 2015 Dec; 6(39):42243-57. PubMed ID: 26544626
[TBL] [Abstract][Full Text] [Related]
12. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
Miettinen M; Majidi M; Lasota J
Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
[TBL] [Abstract][Full Text] [Related]
13. KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
Incorvaia L; De Biase D; Nannini M; Fumagalli E; Vincenzi B; De Luca I; Brando C; Perez A; Pantaleo MA; Gasperoni S; D'Ambrosio L; Grignani G; Maloberti T; Pedone E; Bazan Russo TD; Mazzocca A; Algeri L; Dimino A; Barraco N; Serino R; Gristina V; Galvano A; Bazan V; Russo A; Badalamenti G
Oncologist; 2024 Jan; 29(1):e141-e151. PubMed ID: 37463014
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
15. Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis.
Liang CW; Yang CY; Flavin R; Fletcher JA; Lu TP; Lai IR; Li YI; Chang YL; Lee JC
Hum Pathol; 2021 Jan; 107():69-79. PubMed ID: 33186588
[TBL] [Abstract][Full Text] [Related]
16. Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era.
Dermawan JK; Kelly C; Gao Z; Smith S; Jadeja B; Singer S; Tap WD; Chi P; Antonescu CR
Clin Cancer Res; 2023 Oct; 29(19):3974-3985. PubMed ID: 37477937
[TBL] [Abstract][Full Text] [Related]
17. Mutational characteristics of gastrointestinal stromal tumors: A single-center analysis of 302 patients.
Liang L; Li X; Li D; Liu P; Nong L; Dong Y; Liu J; Huang S; Li T
Oncol Lett; 2021 Feb; 21(2):174. PubMed ID: 33552291
[TBL] [Abstract][Full Text] [Related]
18. SETD2 histone modifier loss in aggressive GI stromal tumours.
Huang KK; McPherson JR; Tay ST; Das K; Tan IB; Ng CC; Chia NY; Zhang SL; Myint SS; Hu L; Rajasegaran V; Huang D; Loh JL; Gan A; Sairi AN; Sam XX; Dominguez LT; Lee M; Soo KC; Ooi LL; Ong HS; Chung A; Chow PK; Wong WK; Selvarajan S; Ong CK; Lim KH; Nandi T; Rozen S; Teh BT; Quek R; Tan P
Gut; 2016 Dec; 65(12):1960-1972. PubMed ID: 26338826
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.
Singer S; Rubin BP; Lux ML; Chen CJ; Demetri GD; Fletcher CD; Fletcher JA
J Clin Oncol; 2002 Sep; 20(18):3898-905. PubMed ID: 12228211
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
